BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37468258)

  • 21. Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.
    Brauckhoff M; Machens A; Lorenz K; Bjøro T; Varhaug JE; Dralle H
    Ann Surg; 2014 Apr; 259(4):800-6. PubMed ID: 23979292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late diagnosis of type 2B multiple endocrine neoplasia (MEN 2B) in a 23 year-old patient.
    Andrysiak-Mamos E; Sowińska-Przepiera E; Żochowska E; Kazimierczyk-Puchalska A; Syrenicz J; Lubikowski J; Birkenfeld B; Syrenicz A
    Endokrynol Pol; 2011; 62(6):548-53. PubMed ID: 22144222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid.
    Krausz Y; Rosler A; Guttmann H; Ish-Shalom S; Shibley N; Chisin R; Glaser B
    Clin Nucl Med; 1999 Apr; 24(4):256-60. PubMed ID: 10466522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple endocrine neoplasia type 2B: more than an endocrine disorder.
    O'Riordain DS; O'Brien T; Crotty TB; Gharib H; Grant CS; van Heerden JA
    Surgery; 1995 Dec; 118(6):936-42. PubMed ID: 7491537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple endocrine neoplasia type 2B.
    Nakata S; Okugi H; Saitoh Y; Takahashi H; Shimizu K
    Int J Urol; 2001 Jul; 8(7):398-400. PubMed ID: 11442663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 9 years boy with MEN-2B variant of medullary thyroid carcinoma.
    Sattar MA; Hadi HI; Ekramuddoula FM; Hasanuzzaman SM
    Mymensingh Med J; 2013 Apr; 22(2):406-9. PubMed ID: 23715371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple endocrine neoplasia 2B: delayed presentation, rapid diagnosis.
    Balachandran K; Kamalanathan S; Gopalakrishnan S; Murugananadham K
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].
    Mathiesen JS; Døssing H; Bender L; Godballe C
    Ugeskr Laeger; 2014 Jan; 176(5A):. PubMed ID: 27498810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular manifestations in multiple endocrine neoplasia type 2b.
    Fink A; Lapidot M; Spierer A
    Am J Ophthalmol; 1998 Aug; 126(2):305-7. PubMed ID: 9727527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing and early thyroidectomy for inherited medullary thyroid carcinoma.
    Lairmore TC; Frisella MM; Wells SA
    Ann Med; 1996 Oct; 28(5):401-6. PubMed ID: 8949970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome.
    Eter N; Klingmüller D; Höppner W; Spitznas M
    Graefes Arch Clin Exp Ophthalmol; 2001 Jun; 239(5):391-4. PubMed ID: 11482345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical management and follow-up of medullary thyroid carcinoma.
    Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
    J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Diagnosis and Treatment of Multiple Endocrine Neoplasia Type 2B in Ethnic Han Chinese.
    Zhang ZW; Guo X; Qi XP
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):534-543. PubMed ID: 32914730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
    Niederle B; Sebag F; Brauckhoff M
    Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Late onset of medullary thyroid carcinoma with bilateral adrenal pheochromocytomas in the case of patient with MEN 2].
    Zakrzewska A; Makowska AM; Bar-Andziak E
    Pol Merkur Lekarski; 2004 Dec; 17(102):633-7. PubMed ID: 15771139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
    Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
    Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple endocrine neoplasia type 2: an overview.
    Moline J; Eng C
    Genet Med; 2011 Sep; 13(9):755-64. PubMed ID: 21552134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.